Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. - Kimberlin,D.; Powell,D.; Gruber,W.; Diaz,P.; Arvin,A.; Kumar,M. (Pediatr Infect Disease J, 1996)